来自:luys > 馆藏分类
配色: 字号:
2020 Disseminated intravascular coagulation new identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis
2021-10-10 | 阅:  转:  |  分享 
  
ChangThrombosisJournal(2020)18:25Page21of21
77.CukerA,PeyvandiF.Coronavirusdisease2019(COVID-19):106.RisitanoAM,MastellosDC,Huber-LangM,etal.Complementasatargetin
Hypercoagulability.2020;UpToDate.COVID-19?NatRevImmunol.2020;20:343–4.
78.KarioK,MatsuoT,YamamotoK,KobayashiH.PlasmafactorVIIlevelsin107.ZhangL,ZhaiH,MaS,ChenJ,GaoY.Efficacyoftherapeuticplasma
disseminatedintravascularcoagulation.RinshoByori.1991;39:683–8.exchangeinsevereCOVID-19patients.BrJHaematol.2020.https://doi.org/
79.LeeAYY,ConnorsJM,KreuzigerLB,etal.COVID-19andcoagulopathy:10.1111/bjh.16890Publishedonlineaheadofprint,2020May26.
frequentlyaskedquestions.2020.https://www.hematology.org/covid-19/
covid-19-and-coagulopathy.
Publisher’sNote
80.BellanderBM,SinghraoSK,OhlssonM,MattssonP,SvenssonM.
SpringerNatureremainsneutralwithregardtojurisdictionalclaimsin
Complementactivationinthehumanbrainaftertraumaticheadinjury.J
publishedmapsandinstitutionalaffiliations.
Neurotrauma.2001;18:1295–311.
81.HammadA,WestacottL,ZabenM.Theroleofthecomplementsystemin
traumaticbraininjury:areview.JNeuroinflammation.2018;15:24.
82.ChenM,DahaMR,KallenbergCG.Thecomplementsysteminsystemic
autoimmunedisease.JAutoimmun.2010;34:J276–86.
83.BuurmaA,CohenD,VeraarK,etal.Preeclampsiaischaracterizedby
placentalcomplementdysregulation.Hypertension.2012;60:1332–7.
84.FishelsonZ,KirschfinkM.ComplementC5b-9andcancer:mechanismsof
celldamage,cancercounteractions,andapproachesforintervention.Front
Immunol.2019;10:752.
85.Afshar-KharghanV.Theroleofthecomplementsystemincancer.JClin
Invest.2017;127:780–9.
86.StegallMD,ChedidMF,CornellLD.Theroleofcomplementinantibody-
mediatedrejectioninkidneytransplantation.NatRevNephrol.2012;8:670–8.
87.KerrH,RichardsA.Complement-mediatedinjuryandprotectionof
endothelium:lessonsfromatypicalhaemolyticuraemicsyndrome.
Immunobiology.2012;217:195–203.
88.KurosawaS,Stearns-KurosawaDJ.Complement,thrombotic
microangiopathyanddisseminatedintravascularcoagulation.JIntensive
Care.2014;2:65.
89.MeriS.Complementactivationindiseasespresentingwiththrombotic
microangiopathy.EurJInternMed.2013;24:496–502.
90.TurnerN,NolascoL,NolascoJ,SartainS,MoakeJ.Thrombotic
microangiopathiesandthelinkagebetweenvonWillebrandfactorandthe
alternativecomplementpathway.SeminThrombHemost.2014;40:544–50.
91.AirdWC.Theroleoftheendotheliuminseveresepsisandmultipleorgan
dysfunctionsyndrome.Blood.2003;101:3765–77.
92.SpragueAH,KhalilRA.Inflammatorycytokinesinvasculardysfunctionand
vasculardisease.BiochemPharmacol.2009;78:539–52.
93.ValentijnKM,vanDrielLF,MourikMJ,HendriksGJ,ArendsTJ,KosterAJ,
ValentijnJA.MultigranularexocytosisofWeibel-Paladebodiesinvascular
endothelialcells.Blood.2010;116:1807–16.
94.WangY,OuyangY,LiuB,MaX,DingR.Plateletactivationandantiplatelet
therapyinsepsis:anarrativereview.ThrombRes.2018;166:28–36.
95.YamaguchiK,MajimaM,KatoriM,KakitaA,SugimotoK.Preferential
consumptionofcoagulationfactorsI,V,andVIIIinratendotoxemia.Shock.
2000;14:535–43.
96.NosselHL.Differentialconsumptionofcoagulationfactorsresultingfrom
activationoftheextrinsic(tissuethromboplastin)ortheintrinsic(foreign
surfacecontact)pathways.Blood.1967;29:331–40.
97.HollestelleMJ,GeertzenHG,StraatsburgIH,vanGulikTM,vanMourikJA.
FactorVIIIexpressioninliverdisease.ThrombHaemost.2004;91:267–75.
98.LangleyPG,HughesRD,WilliamsR.IncreasedfactorVIIIcomplexin
fulminanthepaticfailure.ThrombHaemost.1985;54(3):693–6.
99.KellyDA,TuddenhamEG.Haemostaticproblemsinliverdisease.Gut.1986;
27(3):339–49.
100.DoeringCB,JosephsonCD,CraddockHN,LollarP.FactorVIIIexpressionin
azoxymethane-inducedmurinefulminanthepaticfailure.Blood.2002;100:
143–7.
101.KangY.Coagulopathiesinhepaticdisease.LiverTranspl.2000;6:S72–5.
102.LismanT,LeebeekFW,deGrootPG.Haemostaticabnormalitiesinpatients
withliverdisease.JHepatol.2002;37:280–7.
103.HugenholtzGC,AdelmeijerJ,MeijersJC,PorteRJ,StravitzRT,LismanT.An
unbalancebetweenvonWillebrandfactorandADAMTS13inacuteliver
failure:implicationsforhemostasisandclinicaloutcome.Hepatology.2013;
58:752–61.
104.PalyuE,HarsfalviJ,TornaiT,etal.Majorchangesofvonwillebrandfactor
multimerdistributionincirrhoticpatientswithstablediseaseoracute
decompensation.ThrombHaemost.2018;118:1397–408.
105.TurnerNA,MoakeJL.FactorVIIIIssynthesizedinhumanendothelialcells,
packagedinweibel-paladebodiesandsecretedboundtoulvwfstrings.
PLoSOne.2015;10(10):e0140740.
献花(0)
+1
(本文系luys首藏)